COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 943: Articles 9421-9430  | Next

SARS-CoV-2 Viral Genes Compromise Survival and Functions of Human Pluripotent Stem Cell-derived Cardiomyocytes via Reducing Cellular ATP Level
Liu, J., Zhang, Y., Wu, S., Han, L., Wang, C., Liu, S., Simpson, E., Liu, Y., Wang, Y., Shou, W., Liu, Y., Rubart-von der Lohe, M., Wan, J., Wan, J., Yang, L.
10.1101/2022.01.20.477147 — Posted: 2022-01-23
Impact of accelerating booster vaccination amidst Omicron surge in the United States
Sah, P., Nogueira Vilches, T., Moghadas, S. M., Fitzpatrick, M. C., Schneider, E. C., Galvani, A. P.
10.1101/2022.01.22.22269655 — Posted: 2022-01-23
A Cross-Country Analysis of the Effectiveness of COVID-19 Vaccines in Reducing Mortality Rates within the EU
Bliznashki, S.
10.1101/2022.01.23.22269604 — Posted: 2022-01-23
Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 S antibodies
Vargas, L., Valdivieso, N., Tempio, F., Simon, V., Sauma, D., Valenzuela, L., Beltran, C., Castillo-Delgado, L., Contreras-Benavides, X., Acevedo, M. L., Valiente-Echeverria, F., Soto-Rifo, R., Gonzalez, R. I., Lopez, M., Osorio, F., Bono, M. R.
10.1101/2022.01.14.22269289 — Posted: 2022-01-23
COVID-19 and its clinical severity are associated with alterations of plasma sphingolipids and enzyme activities of sphingomyelinase and ceramidase
Mühle, C., Kremer, A., Vetter, M., Schmid, J., Achenbach, S., Schumacher, F., Lenz, B., Cougoule, C., Hoertel, N., Carpinteiro, A., Gulbins, E., Kleuser, B., Kornhuber, J.
10.1101/2022.01.19.22269391 — Posted: 2022-01-23 Discussion: Offsite
Shorter serial intervals in SARS-CoV-2 cases with Omicron variant compared to Delta variant in the Netherlands, 13 - 19 December 2021
Backer, J. A., Eggink, D., Andeweg, S. P., Veldhuijzen, I. K., van Maarseveen, N., Vermaas, K., Vlaemynck, B., Schepers, R., van den Hof, S., Reusken, C., Wallinga, J.
10.1101/2022.01.18.22269217 — Posted: 2022-01-23
ESTIMATING THE EFFECT OF VACCINATION ON THE CASE-FATALITY RATE FOR COVID-19
Murata, G. H., Murata, A. E., Campbell, H. M., Mao, J. T.
10.1101/2022.01.22.22269689 — Posted: 2022-01-23
Risk of COVID-19 Reinfection and Vaccine Breakthrough Infection, Madera County, California, 2021
Nguyen, M., Paul, E., Mills, P. K., Paul, S.
10.1101/2022.01.22.22269105 — Posted: 2022-01-23
Evaluation of the effects of vaccination regimes on the transmission dynamics of COVID-19 pandemic
Nakamoto, I.
10.1101/2022.01.22.22269569 — Posted: 2022-01-23
Beyond vaccination: A Cross-Sectional Study of the importance of Behavioral and Native Factors on COVID-19 Infection and Severity.
Aouissi, H. A., Ababsa, M., Leveau, C., Petrisor, A.-I., Slomka, A., Yasuhara, J., Epelboin, L., Ohmagari, N.
10.1101/2022.01.23.22269214 — Posted: 2022-01-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).